Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2120 (LINC02120) is a human long intergenic non-protein coding RNA (lincRNA) gene, also referred to as CTD-2218G20.2. LincRNAs are non-coding RNAs longer than 200 nucleotides that do not overlap coding genes and are generally involved in regulating gene expression by mechanisms such as chromatin remodeling, transcriptional regulation, RNA stabilization, and genome architecture. Some lincRNAs display tissue-specific expression and may function in disease contexts, including cancer, but there is currently no direct evidence for LINC02120 serving as a therapeutic target or being associated with any drug mechanism of action or biomarker role. The precise biological function and disease association of LINC02120 remain uncharacterized at this time[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2120 (LINC02120).